High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan

Bone Marrow Transplantation

Volumn 46, Issue 4, 2011, Pages 567-572

  Chen, M H ^a,b   Chang, P M ^a,b   Li, W Y ^a,b   Hsiao, L T ^a,b   Hong, Y C ^a,b   Liu, C Y ^a,b   Gau, J P ^a,b   Liu, J H ^a,b   Chen, P M ^a,b   Chiou, T J ^a,b   Tzeng, C H ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

chronic GVHD; hematopoietic SCT; oral squamous cell carcinoma

Indexed keywords

AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; STEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CANCER; ORAL SQUAMOUS CELL CARCINOMA; OVARY CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; VIRUS DETECTION; VIRUS IDENTIFICATION;

ADOLESCENT; ADULT; AGE FACTORS; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79953712015     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.163     Document Type: Article

References (19)

1. Marras TK, Szalai JP, Chan CK, Lipton JH, Messner HA, Laupacis A. Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument. Bone Marrow Transplant 2002; 30: 599-607. (Pubitemid 35414810)
2. Hasegawa W, Pond GR, Rifkind JT, Messner HA, Lau A, Daly AS et al. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation. Bone Marrow Transplant 2005; 35: 51-55. (Pubitemid 40090056)
3. Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003; 21: 1352-1358. (Pubitemid 46606415)
4. Bhatia S, Louie AD, Bhatia R, O'Donnell MR, Fung H, Kashyap A et al. Solid cancer after bone marrow transplanta-tion. J Clin Oncol 2001; 19: 464-471. (Pubitemid 32112860)
5. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Soce G, Travis LB et al. Solid cancer after bone marrow transplanta-tion. N Engl J Med 1997; 336: 897-904. (Pubitemid 27137189)
6. Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant 2005; 36: 115-121. (Pubitemid 41030626)
7. Ahmad I, Cau NV, Kwan J, Maaroufi Y, Meuleman N, Aoun M et al. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation. Transplantation 2009; 87: 1240-1245.
8. Landgren O, Gilbert ES, Rizzo JD, Soce G, Banks PM, Sobocinski KA et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 4992-5001.
9. Curtis RE, Metayer C, Rizzo JD, Soce G, Sobocinski KA, Flowers ME et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005; 105: 3802-3811. (Pubitemid 40662691)
10. Rugarli C, Smeraldi RS, Villa MG, Pello F. HL-A antigens in serum from bone marrow harvested for diagnostic purposes. Biomedicine 1976; 25: 100-104.
11. Little AM, Marsh SG, Madrigal JA. Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection. Curr Opin Hematol 1998; 5: 419-428. (Pubitemid 28521512)
12. Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175-1183.
13. Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348-357. (Pubitemid 30056424)
14. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consump-tion related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-453.
15. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956. (Pubitemid 46740304)
16. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006; 24: 2606-2611. (Pubitemid 46622080)
17. Savani BN, Goodman S, Barrett AJ. Can routine post-transplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation? Clin Cancer Res 2009; 15: 2219-2221.
18. Chen MH, Hsiao LT, Chiou TJ, Liu JH, Gau JP, Teng HW et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 2008; 87: 475-480.
19. Janin A, Murata H, Leboeuf C, Cayuela JM, Gluckman E, Legres L et al. Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation. Blood 2009; 113: 1834-1840.